Sites of action of sleep and wake drugs: insights from model organisms
- Authors
- Rihel, J., and Schier, A.F.
- ID
- ZDB-PUB-130703-31
- Date
- 2013
- Source
- Current opinion in neurobiology 23(5): 831-40 (Journal)
- Registered Authors
- Rihel, Jason, Schier, Alexander
- Keywords
- none
- MeSH Terms
-
- Animals
- Brain/drug effects*
- Brain/physiology*
- Humans
- Sleep/drug effects*
- Sleep/physiology
- Wakefulness/drug effects*
- Wakefulness/physiology
- PubMed
- 23706898 Full text @ Curr. Opin. Neurobiol.
Small molecules have been used since antiquity to regulate our sleep. Despite the explosion of diverse drugs to treat problems of too much or too little sleep, the detailed mechanisms of action and especially the neuronal targets by which these compounds alter human behavioural states are not well understood. Research efforts in model systems such as mouse, zebrafish and fruit fly are combining conditional genetics and optogenetics with pharmacology to map the effects of sleep-promoting drugs onto neural circuits. Recent studies raise the possibility that many small molecules alter sleep and wake via specific sets of critical neurons rather than through the global modulation of multiple brain targets. These findings also uncover novel brain areas as sleep/wake regulators and indicate that the development of circuit-selective drugs might alleviate sleep disorders with fewer side effects.